CME Hours / Accreditation Information
This activity is being sponsored by Boston University School of Medicine.
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this educational activity for a maximum of 10 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Completion of this course will also earn 10 hours of Risk Management CME credits.
Each module will require about 2 hours per week for up to 5 weeks of participation. Participation includes reading and listening to online presentations, taking part in online group discussions, reading and responding to in-depth case studies, applying knowledge and practice to patients, and completing a final self-evaluation.
Physicians can earn additional AMA PRA Category 1 Credit(s)™ in the following way:
- Participate in a “card study”: With the guidance of the course director, participants will identify 4-6 patients meeting the criteria for intervention discussed in each educational module; specific patient information will be collected on the cards; cards will be stored within the participant’s office; at three months post-intervention, updated patient information will be reviewed, de-identified, and reported.
Boston University School of Medicine designates this educational activity for a maximum of 5 AMA PRA Category 1 Credit(s)™.
- The above augmentation requires an additional time commitments. Contact the Boston University CME office (617) 638-4605 or www.bu.edu/cme for more information and to enroll.
Term of Approval
Date of Release: July, 2008
Expiration Date: July, 2011
Course Director
John M. Wiecha, MD, MPH,
Associate Professor
Director, Distance Education for Health
Director of Predoctoral Education
Department of Family Medicine
Boston University School of Medicine
Faculty Member has nothing to disclose with regards to commercial interests.
Course Faculty
Milagros C. Rosal, Ph.D.
Associate Professor of Medicine
Division of Preventive and Behavioral Medicine
Department of Medicine
University of Massachusetts Medical School
Faculty Member has nothing to disclose with regard to commercial interests.
Disclosure Policy
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve apparent conflicts of interest. In addition, faculty members are asked to disclose when any discussion of unapproved use of pharmaceuticals and devices occurs.
Target Audience
Primary care physicians.
Educational Needs Addressed
According to the American Cancer Society, colorectal cancer is the second leading cause of cancer-related deaths in the United States. Colorectal cancer is also the third most common diagnosed cancer among men and women in the U.S., with 112,340 new cases of colon cancer and 41,420 new cases of rectal cancer expected for diagnosis in 2007.¹ Although the National Cancer Institute advocates screening for colon cancer as routine care for all adults aged 50 year or older,² Dr. Jennifer Hass and her associates recently conducted statistical analysis of data from the National Health Interview Survey and found that only 50.2% of adults aged 50 years or older had ever been screened for colorectal cancer.³ Of colorectal cancer diagnoses, only 39% occur during the early stages, when the cancer has a better survival rate and there are fewer symptoms. If diagnosed and treated during an early stage, there is a greater than 90% 5-year relative survival rate.
An alarming reason for low rate of early detection is physicians’ misconceptions about patients’ willingness to be screened. Haas, et al’s analysis supported earlier works that suggested that lower rates of screening are associated with a lack of provider counseling about Colorectal Cancer Screening. The analysis also found that overall only 37.4% of physicians correctly recommended both initiation and frequency of colorectal cancer screening.³ The purpose of this educational program is to help primary care physicians identify patients who are at risk for Colorectal Cancer, implement recommended motivational interviewing techniques, and increase colorectal cancer screening rates among their patient populations.
Needs Assessment References:
¹http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_colon_and_rectum_cancer.asp?sitearea=
² http://www.cancer.gov/cancertopics/pdq/treatment/colon/healthprofessional
³ Haas, JS, Fitzmaurice G, Brawarsky P, Liang S, Hiatt RA, Klabunde CN, et al. Association of regional variation in primary care physicans’ colorectal cancer screening recommendations with individual use of colorectal cancer screening. Prev Chronic Dis 2007; 4(4). http://www.cdc.gov/pcd/issues/2007/oct/06_0140.htm. Accessed 09/21/2007.
http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_colon_and_rectum_cancer.asp?sitearea=
Sarfaty, M. How to increase colorectal cancer screening rates in practice: A primary care clinician’s evidence-based toolbox and guide. American Cancer Society, 2006. http://www.cancer.org/docroot/PRO/content/PRO_4_1x_ColonMD_Clinicians_Manual.pdf.asp . Accessed 10/22/07.
Program Learning Objectives
At the conclusion of the seven modules of this program, participants will be able to:
- Describe practical theories and models of health behavior change that help promote CRC screening.
- Demonstrate how to apply the above theories using counseling skills (Motivational Interviewing) that will help patients make decisions about CRC screening.
- Model effectiveness in counseling patients for CRC screening by applying the model and counseling skills to patients.
Disclaimer
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. NEITHER TRUSTEES OF BOSTON UNIVERSITY NOR THE DEVELOPERS OF THE MATERIALS MAKE ANY WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL THE TRUSTEES OF BOSTON UNIVERSITY OR THE DEVELOPERS OF THESE MATERIALS BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.
Funding
This project was made possible through a grant from the Physicians' Foundation for Health Systems Excellence and is supported in part by unrestricted educational grants from Pfizer, GlaxoSmithKline, The Olympus Medical Charitable Foundation, and Beckman Coulter.
|
